Tiziana Life Sciences PLC’s (LON:TILS) (NASDAQ:TLSA) Dr Howard Weiner speaks to Proactive’s Polly Middlehurst following the news it’s submitted a patent application covering the potential use of nasally-administered and orally taken Foralumab for the treatment of COVID-19. Dr Weiner is…
Tag